Nuveen Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $24M | Sell |
77,869
-11,125
| -13% | -$3.43M | 0.01% | 1055 |
|
|
2024
Q3 | $18.9M | Buy |
88,994
+8,195
| +10% | +$1.74M | 0.01% | 1231 |
|
|
2024
Q2 | $22.6M | Buy |
80,799
+10,087
| +14% | +$2.83M | 0.01% | 1049 |
|
|
2024
Q1 | $18.9M | Buy |
70,712
+10,840
| +18% | +$2.89M | 0.01% | 1218 |
|
|
2023
Q4 | $13.9M | Buy |
59,872
+20,337
| +51% | +$4.71M | ﹤0.01% | 1382 |
|
|
2023
Q3 | $5.77M | Sell |
39,535
-8,927
| -18% | -$1.3M | ﹤0.01% | 1788 |
|
|
2023
Q2 | $11.2M | Buy |
48,462
+12,236
| +34% | +$2.83M | ﹤0.01% | 1436 |
|
|
2023
Q1 | $8.78M | Sell |
36,226
-544
| -1% | -$132K | ﹤0.01% | 1564 |
|
|
2022
Q4 | $2.35M | Buy |
36,770
+1,549
| +4% | +$98.8K | ﹤0.01% | 2305 |
|
|
2022
Q3 | $2.29M | Buy |
35,221
+205
| +0.6% | +$13.3K | ﹤0.01% | 2335 |
|
|
2022
Q2 | $2.51M | Buy |
35,016
+1,887
| +6% | +$135K | ﹤0.01% | 2323 |
|
|
2022
Q1 | $3.14M | Sell |
33,129
-23,585
| -42% | -$2.23M | ﹤0.01% | 2293 |
|
|
2021
Q4 | $4.05M | Sell |
56,714
-9,567
| -14% | -$683K | ﹤0.01% | 2237 |
|
|
2021
Q3 | $5.42M | Buy |
66,281
+6,013
| +10% | +$492K | ﹤0.01% | 2159 |
|
|
2021
Q2 | $5.87M | Buy |
60,268
+28,627
| +90% | +$2.79M | ﹤0.01% | 2168 |
|
|
2021
Q1 | $3.7M | Sell |
31,641
-30
| -0.1% | -$3.51K | ﹤0.01% | 2320 |
|
|
2020
Q4 | $3.52M | Sell |
31,671
-1,720
| -5% | -$191K | ﹤0.01% | 2246 |
|
|
2020
Q3 | $3.96M | Buy |
33,391
+260
| +0.8% | +$30.9K | ﹤0.01% | 2045 |
|
|
2020
Q2 | $3.75M | Sell |
33,131
-2,721
| -8% | -$308K | ﹤0.01% | 2055 |
|
|
2020
Q1 | $2.39M | Buy |
35,852
+2,679
| +8% | +$179K | ﹤0.01% | 2104 |
|
|
2019
Q4 | $3.02M | Sell |
33,173
-682
| -2% | -$62.2K | ﹤0.01% | 2240 |
|
|
2019
Q3 | $2.92M | Buy |
33,855
+1,304
| +4% | +$112K | ﹤0.01% | 2230 |
|
|
2019
Q2 | $3.41M | Buy |
+32,551
| New | +$3.41M | ﹤0.01% | 2183 |
|